In the field of regenerative medicine and cellular therapies, one strategic principle often overlooked is the importance of harvesting and cryopreserving as many viable cells as possible at initial collection . While cell expansion technologies can be valuable, they should not be considered a full substitute for a high‑yield initial cell bank. Below are the key reasons why quantity matters and quality persists. 1. Cellular Potency and Aging with In Vitro Expansion When cells are expanded in...

Multilineage-differentiating Stress-Enduring or Muse cells are a rare subset (~1%) of mesenchymal stem cells identified by the marker...

In a landmark decision in December 2024, the U.S. Food and Drug Administration (FDA) approved Remestemcel‑L (brand name: Ryoncil)...